Table 2. Clinical symptoms before and at one month after DEB-TACE.
| Clinical symptoms | Before DEB-TACE (n=25) | One month after DEB-TACE (n=25) | P |
|---|---|---|---|
| Cough grade, n (%) | 0.308 | ||
| No | 10 (40.0) | 8 (32.0) | |
| Mild | 9 (36.0) | 16 (64.0) | |
| Moderate | 4 (16.0) | 1 (4.0) | |
| Severe | 2 (8.0) | 0 (0.0) | |
| Hemoptysis grade, n (%) | 0.564 | ||
| No | 22 (88.0) | 23 (92.0) | |
| Mild | 3 (12.0) | 2 (8.0) | |
| Moderate | 0 (0.0) | 0 (0.0) | |
| Severe | 0 (0.0) | 0 (0.0) | |
| Chest distress grade, n (%) | 0.013 | ||
| No | 15 (60.0) | 22 (88.0) | |
| Mild | 7 (28.0) | 3 (12.0) | |
| Moderate | 3 (12.0) | 0 (0.0) | |
| Severe | 0 (0.0) | 0 (0.0) | |
| Chest pain grade, n (%) | 1.000 | ||
| No | 23 (92.0) | 22 (88.0) | |
| Mild | 1 (4.0) | 3 (12.0) | |
| Moderate | 1 (4.0) | 0 (0.0) | |
| Severe | 0 (0.0) | 0 (0.0) | |
| Dyspnea grade, n (%) | 0.025 | ||
| No | 19 (76.0) | 24 (94.0) | |
| Mild | 6 (24.0) | 1 (6.0) | |
| Moderate | 0 (0.0) | 0 (0.0) | |
| Severe | 0 (0.0) | 0 (0.0) |
Data were presented as count (percentage). Comparisons were determined by Wilcoxon signed rank test. P<0.05 was considered significant. DEB-TACE, drug-eluting beads-transcatheter arterial chemoembolization.